OGXI : Analysis & Opinions

  1. OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst ...

    December 17, 2014
    OncoGenex Pharmaceuticals, Inc. (OGXI) has completed enrolling patients in its phase II Rainier study on apatorsen for previously ...
  2. Isis Pharma Updates on its Pipeline - Analyst Blog

    January 11, 2013
    Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust pipeline. The ...
  3. Four High-Flying Pharmaceutical Companies

    October 28, 2009
    A look at some of the best-performing stocks year to date - up anywhere from 400% to 2000%.
Trading Center